← Back to Clinical Trials
Recruiting NCT05753137

Acupuncture as Adjuvant Therapy for Glaucoma - Protocol for a Randomized Controlled Trial

Trial Parameters

Condition Glaucoma
Sponsor China Medical University Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 20 Years
Max Age N/A
Start Date 2023-06-28
Completion 2025-06-27
Interventions
AcupunctureAcupuncture placebo

Brief Summary

This clinical trial used acupuncture as an adjunctive treatment for glaucoma patients. A randomized, controlled trial involving 50 subjects will be conducted and observed for 12 weeks to evaluate the clinical efficacy of acupuncture. This study aims to provide a reference for future clinical treatment guidelines.

Eligibility Criteria

Inclusion Criteria: 1. Primary open angle glaucoma diagnosed at least 3 months ago. 2. Diagnosed with mild or moderate open angel glaucoma. 3. Use 1 or 2 kinds of glaucoma drugs. 4. Age ≥ 20 years old. 5. Participants sign the informed consent and cooperate with the experimental procedures. Exclusion Criteria: 1. Accept any ophthalmic laser or surgery within one year. 2. High myopia. 3. Use of any drugs that affect intraocular pressure. 4. Visual acuity with correction lower than 0.2. 5. Previous or existing uveitis or retinopathy. 6. Unable to receive acupuncture treatment continuously or allergic to acupuncture needles. 7. Pregnancy or breastfeeding. 8. Refusal to sign the informed consent form.

Related Trials